Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

v3.22.1
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net loss $ (76,808) $ (188,619)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,786 5,994
Reduction in the carrying amount of ROU assets 6,862 6,070
Accretion of discount on short-term investments (28) 0
Stock-based compensation 29,247 36,895
Non-cash severance expense 0 7,873
Change in deferred tax asset valuation allowance 0 (2,637)
Change in fair value of derivative liabilities (65,810) 0
Changes in operating assets and liabilities    
Contract asset 5,502 0
Prepaid expenses and other current assets 11,730 844
Other assets (772) (4,824)
Accounts payable (7,655) 4,767
Accrued expenses and other current and non-current liabilities (37,545) (13,011)
Operating lease liability (6,322) (4,326)
Net cash used in operating activities (135,813) (150,974)
Cash flows from investing activities    
Purchases of property and equipment (5,513) (3,381)
Net cash acquired in acquisitions 0 294,439
Purchase of short-term investments (966,063) 0
Net cash (used in) provided by investing activities (971,576) 291,058
Cash flows from financing activities    
Proceeds from issuance of common stock 1,921 617
Proceeds from issuance of Series U-2 preferred stock, net 0 397,862
Principal repayments of finance leases (86) 0
Net cash provided by financing activities 1,835 398,479
Net (decrease) increase in cash, cash equivalents and restricted cash (1,105,554) 538,563
Cash, cash equivalents, and restricted cash at beginning of the period 1,626,247 399,828
Cash, cash equivalents, and restricted cash at end of the period $ 520,693 $ 938,391